Authors : Bibi Shazia Sabir

Volume/Issue : Volume 9 - 2024, Issue 7 - July

Google Scholar : https://tinyurl.com/9c2ufe2z

Scribd : https://tinyurl.com/3jrcprw5

DOI : https://doi.org/10.38124/ijisrt/IJISRT24JUL447

Abstract : Epigenetics are the changes due to DNA methylation, histone modifications, and noncoding RNA regulation, which play a crucial part in the expression of genes. Although these changes do not alter the sequence of the DNA, they are significant in determining the phenotype and inheritance of the genes. The impact of epigenetics on inherited diseases like Fragile X syndrome, Angelman syndrome, and Prader-Willi syndrome emphasizes the significance of studying epigenetic dysregulation in disease pathology. The current review aims to investigate the role of epigenetic mechanisms in inherited diseases and to evaluate the utility of molecular diagnostic tools for epigenetic analysis in disease diagnosis. Case studies of diseases such as Duchenne muscular dystrophy and Prader-Willi syndrome highlight the clinical relevance of epigenetic analysis in disease diagnosis and management. This research is conducted through an extensive analysis of recent literature to explore the epigenetic mechanisms underlying inherited diseases. Additionally, advanced molecular diagnostic techniques like droplet digital PCR (ddPCR), transposase-based bisulfite tagging, and data mining coupled with conventional experimental procedures. However, the intricate relationship between genetic and epigenetic factors and challenges related to inclined data need to be addressed. Future research endeavors to elucidate the role of epigenetic modifications in disease pathogenesis and develop strategies for personalized medicinal treatment and therapeutic intervention.

References :

1. Alghamdi, F., Al-Tawari, A., Alrohaif, H., Alshuaibi, W., Mansour, H., Aartsma-Rus, A., & Mégarbané, A. (2021). Case Report: The Genetic Diagnosis of Duchenne Muscular Dystrophy in the Middle East. Frontiers in Pediatrics, 9, 716424. https://doi.org/10.3389/fped.2021.716424
2. Al-Hayali, M. A., Sozer, V., Durmus, S., Erdenen, F., Altunoglu, E., Gelisgen, R., Atukeren, P., Atak, P. G., & Uzun, H. (2019). Clinical Value of Circulating Microribonucleic Acids miR-1 and miR-21 in Evaluating the Diagnosis of Acute Heart Failure in Asymptomatic Type 2 Diabetic Patients. Biomolecules, 9(5), 193. https://doi.org/10.3390/biom9050193
3. Araki, K., Kurosawa, A., & Kumon, H. (2022). Development of a quantitative methylation-specific droplet digital PCR assay for detecting Dickkopf-related protein 3. BMC Research Notes, 15(1), 169. https://doi.org/10.1186/s13104-022-06056-6
4. Belay, K. E., Ayalew, B. L., Amogne, M. T., Alemneh, T. A., & Geletew, T. K. (2023). A 14-year-old male patient with diagnosis of Prader–Willi syndrome in Ethiopia: A case report. Journal of Medical Case Reports, 17(1), 530. https://doi.org/10.1186/s13256-023-04282-5
5. Casas, E., & Vavouri, T. (2020). Mechanisms of epigenetic inheritance of variable traits through the germline. Reproduction, 159(6), R251–R263. https://doi.org/10.1530/REP-19-0340
6. Fallet, M., Blanc, M., Di Criscio, M., Antczak, P., Engwall, M., Guerrero Bosagna, C., Rüegg, J., & Keiter, S. H. (2023). Present and future challenges for the investigation of transgenerational epigenetic inheritance. Environment International, 172, 107776. https://doi.org/10.1016/j.envint.2023.107776
7. Garcia-Gimenez, J. L. (2015). Epigenetic Biomarkers and Diagnostics. Academic Press
8. Gershman, A., Sauria, M. E. G., Guitart, X., Vollger, M. R., Hook, P. W., Hoyt, S. J., Jain, M., Shumate, A., Razaghi, R., Koren, S., Altemose, N., Caldas, G. V., Logsdon, G. A., Rhie, A., Eichler, E. E., Schatz, M. C., O’Neill, R. J., Phillippy, A. M., Miga, K. H., & Timp, W. (2022). Epigenetic patterns in a complete human genome. Science, 376(6588), eabj5089. https://doi.org/10.1126/science.abj5089
9. Griñán-Ferré, C., Corpas, R., Puigoriol-Illamola, D., Palomera-Ávalos, V., Sanfeliu, C., & Pallàs, M. (2018). Understanding Epigenetics in the Neurodegeneration of Alzheimer’s Disease: SAMP8 Mouse Model. Journal of Alzheimer’s Disease, 62(3), 943–963. https://doi.org/10.3233/JAD-170664
10. Harvey, Z. H., Chen, Y., & Jarosz, D. F. (2018). Protein-Based Inheritance: Epigenetics beyond the Chromosome. Molecular Cell, 69(2), 195–202. https://doi.org/10.1016/j.molcel.2017.10.030
11. Husby, A. (2022). Wild epigenetics: Insights from epigenetic studies on natural populations. Proceedings of the Royal Society B: Biological Sciences, 289(1968), 20211633. https://doi.org/10.1098/rspb.2021.1633
12. Janssens, Y., Wynendaele, E., Vanden Berghe, W., & De Spiegeleer, B. (2019). Peptides as epigenetic modulators: Therapeutic implications. Clinical Epigenetics, 11(1), 101. https://doi.org/10.1186/s13148-019-0700-7
13. Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., Ziller, M. J., Amin, V., Whitaker, J. W., Schultz, M. D., Ward, L. D., Sarkar, A., Quon, G., Sandstrom, R. S., Eaton, M. L., Wu, Y.-C., … Kellis, M. (2015). Integrative analysis of 111 reference human epigenomes. Nature, 518(7539), 317–330. https://doi.org/10.1038/nature14248
14. Menezo, Y., Elder, K., Clement, P., Clement, A., & Patrizio, P. (2022). Biochemical Hazards during Three Phases of Assisted Reproductive Technology: Repercussions Associated with and Imprinting. International Journal of Molecular Sciences, 23(16), Article 16. https://doi.org/10.3390/ijms23168916
15. Nilsson, E. E., Sadler-Riggleman, I., & Skinner, M. K. (2018). Environmentally induced epigenetic transgenerational inheritance of disease. Environmental Epigenetics, 4(2), dvy016. https://doi.org/10.1093/eep/dvy016
16. Ortiz-Barahona, V., Soler, M., Davalos, V., García-Prieto, C. A., Janin, M., Setien, F., Fernández-Rebollo, I., Bech-Serra, J. J., De La Torre, C., Guil, S., Villanueva, A., Zhang, P.-H., Yang, L., Guarnacci, M., Schumann, U., Preiss, T., Balaseviciute, U., Montal, R., Llovet, J. M., & Esteller, M. (2023). Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer. Molecular Cancer, 22(1), 83. https://doi.org/10.1186/s12943-023-01785-z
17. Rugowska, A., Starosta, A., & Konieczny, P. (2021). Epigenetic modifications in muscle regeneration and progression of Duchenne muscular dystrophy. Clinical Epigenetics, 13(1), 13. https://doi.org/10.1186/s13148-021-01001-z
18. Suzuki, M., Liao, W., Wos, F., Johnston, A. D., DeGrazia, J., Ishii, J., Bloom, T., Zody, M. C., Germer, S., & Greally, J. M. (2018). Whole-genome bisulfite sequencing with improved accuracy and cost. Genome Research, 28(9), 1364–1371. https://doi.org/10.1101/gr.232587.117
19. Thiagalingam, S. (2020). Epigenetic memory in development and disease: Unraveling the mechanism. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1873(2), 188349. https://doi.org/10.1016/j.bbcan.2020.188349
20. Xiong, X., Chen, H., Zhang, Q., Liu, Y., & Xu, C. (2024). Uncovering the roles of DNA hemi-methylation in transcriptional regulation using MspJI-assisted hemi-methylation sequencing. Nucleic Acids Research, gkae023. https://doi.org/10.1093/nar/gkae023
21. Zhang, J., Xie, S., & Wan, S. (2021). Cancer Biomarkers Discovery of Methylation Modification With Direct High-Throughput Nanopore Sequencing. Frontiers in Genetics, 12. https://doi.org/10.3389/fgene.2021.672804
22. Zhao, Z., & Shilatifard, A. (2019). Epigenetic modifications of histones in cancer. Genome Biology, 20(1), 245. https://doi.org/10.1186/s13059-019-1870-5